The European Commission approved Pfizer's respiratory syncytial virus vaccine for the prevention of lower respiratory tract ...

Abrysvo is now approved in the EU for adults aged 18 to 59 who are at increased risk of lower respiratory tract disease ...

Pfizer’s (PFE) stock has fallen ill since the COVID-19 pandemic waned, and it is still experiencing some aftereffects. The ...

Denmark's Bavarian Nordic said on Monday the U.S. Food and Drug Administration has approved a freeze-dried formulation of its ...

Pfizer has won European Commission expanded approval of its Abrysvo vaccine for respiratory syncytial virus, or RSV, for use in all adults. The New York drugmaker on Tuesday said the extended ...

Vaxcyte’s stock has dropped around 45% despite a Phase II trial of its invasive pneumococcal disease (IPD) vaccine meeting ...

Analysts at BMO Capital Markets expressed that this departure might undermine the FDA's mission, stressing that the agency's independence is vital for delivering safe and effective treatments. As the ...

Promulgating three core myths, advocates for maintaining the status quo of public funding have been active in the media, but ...

Significant layoffs across the FDA, CDC and NIH are ushering in a new era of public health under the Trump administration.

US pharmaceutical giant Pfizer's new research and development (R&D) centre officially opened at BioPark in the Beijing Economic-Technological Development Area (BDA).As the company's third R&D centre ...

A reported 3500 US Food & Drug Administration staff are headed for the guillotine, as part of Trump's broader purge of the health bureaucracy.

Many investor eyes were on the pharmaceutical industry on Tuesday, and not necessarily for the right reasons. The Trump ...